WO2005042445A2 - フッ素化されたペンタセン誘導体及びそれらの製造方法 - Google Patents
フッ素化されたペンタセン誘導体及びそれらの製造方法 Download PDFInfo
- Publication number
- WO2005042445A2 WO2005042445A2 PCT/JP2004/016248 JP2004016248W WO2005042445A2 WO 2005042445 A2 WO2005042445 A2 WO 2005042445A2 JP 2004016248 W JP2004016248 W JP 2004016248W WO 2005042445 A2 WO2005042445 A2 WO 2005042445A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- substituted
- group
- unsubstituted
- formula
- monocyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C25/00—Compounds containing at least one halogen atom bound to a six-membered aromatic ring
- C07C25/18—Polycyclic aromatic halogenated hydrocarbons
- C07C25/22—Polycyclic aromatic halogenated hydrocarbons with condensed rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C17/00—Preparation of halogenated hydrocarbons
- C07C17/093—Preparation of halogenated hydrocarbons by replacement by halogens
- C07C17/18—Preparation of halogenated hydrocarbons by replacement by halogens of oxygen atoms of carbonyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C17/00—Preparation of halogenated hydrocarbons
- C07C17/23—Preparation of halogenated hydrocarbons by dehalogenation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/63—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C46/00—Preparation of quinones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C50/00—Quinones
- C07C50/26—Quinones containing groups having oxygen atoms singly bound to carbon atoms
- C07C50/36—Quinones containing groups having oxygen atoms singly bound to carbon atoms the quinoid structure being part of a condensed ring system having four or more rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/52—Ortho- or ortho- and peri-condensed systems containing five condensed rings
Definitions
- the present invention relates to a fluorinated pentacene derivative and a method for producing the same.
- the fluorine-containing pentacene-based compound can be used in a wide variety of fields, including organic electronic materials, functional polymer materials, medicines, and agricultural chemicals, and can be used as a raw material particularly in these fields. It is a useful compound.
- Non-Patent Document 4 hexafluorobenzene (see Non-Patent Document 4), octafluoronaphthalene (see Non-Patent Document 57), and decafluoropyrene (see Non-Patent Document 8) can be obtained by this method.
- the defluorination reaction using a metal as a reducing agent proceeds under mild conditions.
- the reaction temperature is 225-280 ° C
- 1,2,3,4,5,6,7,8,9,9,10,10-dodecafluoro-9,10- Decafluoroanthracene can also be obtained from dihydroanthracene (see Non-Patent Document 9).
- 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8-hexadecaful -1,2,3, Octafluoronaphthalene can be obtained from 4,5,6,7,8-octahydronaphthalene (see Non-Patent Document 10).
- Non-Patent Document 1 J. Am. Chem. Soc. 1947, 69, 947
- Non-Patent Document 2 Indust. Engng. Chem. 1947, 39, 393
- Non-Patent Document 3 J. Am. Chem. Soc. 1943, 65, 2064
- Non-Patent Document 4 J. Am. Chem. Soc. 1938, 60, 492
- Non-Patent Document 5 Nature, 1959, Volume 183, Page 588
- Non-Patent Document 6 Science, 1996, 271 pages, 340 pages
- Non-Patent Document 7 J. Org.Chem. 1992, 57, 2856
- Non-Patent Document 8 Tetrahedron, 1963, Vol. 19, p. 1893
- Non-Patent Document 9 Zh. Org.Khim. 1971, Vol. 7, p. 745
- Non-Patent Document 10 J. Fluorine Chem. 1990, 48 volumes, 29 pages
- the present invention has been made in view of the above-mentioned circumstances, and has been made in view of the above circumstances, and it has been found that a fluorinated pentacene derivative, for example, tetradecafluoropentacene which is a novel conjugate, 5, 6, 7, 12, Providing 13,14-hexafluoropentacene, 5,7,12,14-tetrafluoropentacene, 6,13-difluoro-opening pentacene, providing intermediates thereof, and fluorination It is an object of the present invention to provide a method for producing a pentacene derivative and an intermediate thereof. Means for solving the problem
- the present inventors have conducted intensive studies to solve these problems, and as a result, introduced an oxo group, a hydroxyl group, or an alkoxyl group into the pentacene skeleton, fluorinated with sulfur tetrafluoride, and reduced with a reducing agent.
- the inventors have found that a desired position of the pentacene skeleton can be fluorinated by partially defluorinating, and have completed the present invention.
- the gist of the present invention is as follows.
- X 1 , x 2 , x 3 , x 4 , x 5 , x 6 , x 7 , x 8 , x 9 , X 1 , X 11 , x 12 , x 13 , and X 14 are fluorine.
- Hydrogen a substituted or unsubstituted alkyl group having 18 carbon atoms, a substituted or unsubstituted fur group, a substituted or unsubstituted naphthyl group, a substituted or unsubstituted anthracel group, a substituted or unsubstituted naphthase group A phenyl group or a substituted or unsubstituted pentacell group, which may be the same or different;
- X 2 and X 3 combine to form a monocyclic or condensed polycyclic hydrocarbon group, and Z or, X 9 and chi omega is bonded to a monocyclic or condensed polycyclic hydrocarbon group To form )
- X pairs 5 and X ", the pair of X 6 and X 13, and X 7 and compound even without least selected from the pairs mosquito ⁇ et group consisting one pair of groups are both fluorine of X 12.
- X 1, X 2, X 3, X 4, X 8, X 9, ⁇ ⁇ , and X 11 are fluorine, hydrogen, substituted or unsubstituted alkyl group having 1 one 8 carbon atoms, a substituted or An unsubstituted phenyl group, a substituted or unsubstituted naphthyl group, a substituted or unsubstituted anthracel group, a substituted or unsubstituted naphthacyl group, or a substituted or unsubstituted pentacelle group Represent the same or different;
- X 2 and X 3 combine to form a monocyclic or condensed polycyclic hydrocarbon group, and z or, X 9 and chi omega is bonded to a monocyclic or condensed polycyclic hydrocarbon group To form )
- X 11 , x 12 , and x 14 represent fluorine, hydrogen, carbon number 11
- X 2 and X 3 combine to form a monocyclic or condensed polycyclic hydrocarbon group, and z or, X 9 and chi omega is bonded to a monocyclic or condensed polycyclic hydrocarbon group To form )
- X 1 , x 2 , x 3 , x 4 , x 6 , x 8 , x 9 , x 10 , X 11 , and x 13 represent fluorine, hydrogen, carbon atoms of 11
- a substituted or unsubstituted alkyl group a substituted or unsubstituted phenyl group, a substituted or unsubstituted naphthyl group, a substituted or unsubstituted anthracenyl group, a substituted or unsubstituted naphthacyl group, or Represents a substituted or unsubstituted pentacell group, which may be the same or different;
- X 2 and X 3 combine to form a monocyclic or condensed polycyclic hydrocarbon group, and z or, X 9 and chi omega is bonded to a monocyclic or condensed polycyclic hydrocarbon group To form )
- X 1 , X 2 , X 3 , and X 4 are fluorine, hydrogen, a substituted or unsubstituted alkyl group having 18 carbon atoms, a substituted or unsubstituted phenyl group, a substituted or unsubstituted naphthyl Or a substituted or unsubstituted anthracyl group, a substituted or unsubstituted naphthacenyl group, or a substituted or unsubstituted pentacenyl group, which may be the same or different; or X 2 and X 3 Combine to form a monocyclic or fused polycyclic hydrocarbon group.
- X 8, X 9, chi omega, and X 11 are fluorine, hydrogen, substituted or unsubstituted alkyl group having 1 one 8 carbon atoms, a substituted or unsubstituted phenyl group, a substituted or unsubstituted naphthyl Or a substituted or unsubstituted anthracenyl group, a substituted or unsubstituted naphthacenyl group, or a substituted or unsubstituted pentacenyl group, which may be the same or different; or X 9 and X 1Q Combine to form a monocyclic or fused polycyclic hydrocarbon group.
- X 1 , X 2 , X 3 , X 4 , X 9, chi omega, and X 11 are fluorine, hydrogen, substituted or unsubstituted alkyl group having 1 one 8 carbon atoms, a substituted or unsubstituted off group, substituted or Mu ⁇ conversion naphthyl group, a substituted or Represents an unsubstituted anthracel group, a substituted or unsubstituted naphthacyl group, or a substituted or unsubstituted pentacelle group, which may be the same or different;
- X 2 and X 3 combine to form a monocyclic or condensed polycyclic hydrocarbon group, and z or, X 9 and chi omega is bonded to a monocyclic or condensed polycyclic hydrocarbon group To form )
- a compound represented by the formula [13] is reacted with a fluorinating agent to obtain a compound represented by the formula [15]: [0018]
- a method for producing a compound represented by the formula [2], comprising a step of reacting a compound represented by the formula [14] with a reducing agent to produce a compound represented by the formula [2].
- a method for producing a compound represented by the formula [2], comprising a step of reacting a compound represented by the formula [16] with a reducing agent to produce a compound represented by the formula [2].
- X 1 , x 2 , x 3 , x 4 , x 5 , x 7 , x 8 , x 9 , x 1 Q , X 11 , x 12 , and X 14 are fluorine, hydrogen, and carbon atoms.
- X 2 and X 3 combine to form a monocyclic or condensed polycyclic hydrocarbon group, and z or, X 9 and chi omega is bonded to a monocyclic or condensed polycyclic hydrocarbon group To form )
- a method for producing a compound represented by the formula [22], comprising a step of producing a compound represented by the formula: [20]
- a compound represented by the formula [21] is reacted with a fluorinating agent to give a compound of the formula [23] [0022] [Formula 16]
- a compound represented by the formula [23] is reacted with a fluorinating agent to give a compound of the formula [22]
- a method for producing a compound represented by formula [3], comprising a step of reacting a compound represented by formula [22] with a fluorinating agent to produce a compound represented by formula [3] .
- x 2 and x 3 are bonded to form a monocyclic or condensed polycyclic hydrocarbon group, and z or, X 9 and chi omega is bonded to a monocyclic or condensed polycyclic hydrocarbon group To form
- X 9 and chi omega is bonded to a monocyclic or condensed polycyclic hydrocarbon group To form
- a compound represented by the formula [31] is reacted with a fluorinating agent to obtain a compound represented by the formula [33]:
- a method for producing a compound represented by the formula [4], comprising a method of reacting a compound represented by the formula [32] with a reducing agent to produce a compound represented by the formula [4].
- a fluorine group can be regioselectively introduced into the pentacene skeleton, and a fluorinated pentacene derivative can be synthesized.
- the pentacene skeleton refers to a skeleton in which 5 or more 6-membered carbon rings are condensed.
- a fluorinated pentacene derivative is a compound in which at least one of the carbon atoms forming the pentacene skeleton is bonded to fluorine.
- a partially fluorinated pentacene derivative is a compound in which at least one of the carbon atoms forming the pentacene skeleton is bonded to fluorine and at least one is not bonded to fluorine.
- an oxygen functional group is bonded to a carbon atom at a desired position.
- the oxygen functional group refers to a functional group that forms a bond with a carbon atom forming a pentacene skeleton by an oxygen atom, and includes an oxo group, a hydroxyl group, and an alkoxyl group.
- an oxygen functional group is removed from the carbon atom by a fluorination reaction, and instead, two fluorine groups are bonded to one carbon atom. A partial defluorination then removes one fluorine group per carbon atom.
- the fluorinated pentacene derivative produced by the present invention has the formula [1]:
- X 1 , X 2 , X 3 , X 4 , X 5 , X., X 7 , X 8 , X 9 , X 1 , X 11 , X 12 , X 13 , and X 14 are fluorine , Hydrogen, a substituted or unsubstituted alkyl group having 18 carbon atoms, a substituted or unsubstituted fur group, a substituted or unsubstituted naphthyl group, a substituted or unsubstituted anthracel group, a substituted or unsubstituted Represents a naphthacyl group or a substituted or unsubstituted pentacell group, which may be the same or different;
- X 2 and X 3 combine to form a monocyclic or fused polycyclic hydrocarbon group, And z or, form a bonded x 9 and x 1Q monocyclic or condensed polycyclic hydrocarbon group.
- a pair of X 5 and X " are compounds pairs, and pairs mosquito ⁇ et made even without least selected from the group of one pair groups of X 7 and X 12 are each a fluorine X 6 and X 13 .
- X 1 , X 2 , X 3 , X 4 , X 8 , X 9 , X 1 , X 11 , X 12 , and X 14 represent fluorine, hydrogen, substituted or unsubstituted with 18 carbon atoms
- a pentacell group which may be the same or different;
- X 2 and X 3 combine to form a monocyclic or condensed polycyclic hydrocarbon group, and z or, X 9 and chi omega is bonded to a monocyclic or condensed polycyclic hydrocarbon group To form )
- X 11 , ⁇ 12 , and ⁇ 14 are fluorine, hydrogen, carbon number 11 8, a substituted or unsubstituted alkyl group, a substituted or unsubstituted fluorine group, Represents a substituted or unsubstituted naphthyl group, a substituted or unsubstituted anthracenyl group, a substituted or unsubstituted naphthacyl group, or a substituted or unsubstituted pentacel group, which may be the same or different Often;
- X 2 and X 3 combine to form a monocyclic or condensed polycyclic hydrocarbon group, and z or, X 9 and chi omega is bonded to a monocyclic or condensed polycyclic hydrocarbon group To form )
- X 1 , x 2 , x 3 , x 4 , x D , x 8 , x 9 , x 1 Q , X 11 , and x 13 represent fluorine, hydrogen, and carbon atoms.
- a substituted or unsubstituted alkyl group a substituted or unsubstituted phenyl group, a substituted or unsubstituted naphthyl group, a substituted or unsubstituted anthracenyl group, a substituted or unsubstituted naphthacyl group, or Represents a substituted or unsubstituted pentacell group, which may be the same or different;
- X 2 and X 3 combine to form a monocyclic or condensed polycyclic hydrocarbon group, and z or, X 9 and chi omega is bonded to a monocyclic or condensed polycyclic hydrocarbon group To form )
- X 2 and X 3 may combine to form a saturated or unsaturated monocyclic or fused polycyclic hydrocarbon group.
- X 9 and x 1Q also attached may form a monocyclic or fused polycyclic, saturated or unsaturated hydrocarbon group.
- the monocyclic hydrocarbon group also includes a group in which monocyclic hydrocarbon groups are connected to each other by a carbon-carbon single bond.
- the monocyclic or condensed polycyclic hydrocarbon group includes a monocyclic or condensed polycyclic aromatic ring. Examples of the aromatic ring include a benzene ring, a naphthalene ring, and an anthracene ring. The aromatic ring is not limited to these.
- Monocyclic or fused polycyclic hydrocarbon groups may be substituted or unsubstituted.
- x 2 and x 3 combine to form a saturated or unsaturated monocyclic or fused polycyclic hydrocarbon group
- / or X 9 and x 1Q combine to form a saturated or unsaturated Even when forming a monocyclic or fused polycyclic hydrocarbon group, X 1 , x 4 , x 5 , x 6 , x 7 , x 8 , X 11 , x 12 ,
- X 13 and X 14 are as described above.
- the substituted alkyl group includes a fluoroalkyl group.
- the fluoroalkyl group refers to a group in which at least one hydrogen atom of the alkyl group has been substituted with a fluorine atom, and may be further substituted with another substituent.
- the fluoroalkyl group includes a perfluoroalkyl group.
- the substituted phenyl group includes a fluorophenyl group.
- the fluorophenyl group refers to a group in which at least one of the hydrogen atoms of the phenyl group has been substituted with a fluorine atom, and may be further substituted with another substituent.
- the fluorophenyl group includes a pentafluorophenyl group.
- the substituted naphthyl group includes a fluoronaphthyl group.
- the fluoronaphthyl group refers to a group in which at least one of the hydrogen atoms of the naphthyl group has been substituted with a fluorine atom, and may be further substituted with another substituent.
- the fluoronaphthyl group includes a heptafluoronaphthyl group.
- the substituted anthral group includes a fluoronaphthyl group.
- the fluoroanthranol group refers to a group in which at least one hydrogen atom of the anthranyl group has been substituted with a fluorine atom, and may be further substituted with another substituent.
- the fluoroanthranol group includes a nonafluoranthral group.
- the substituted naphthatel group includes a fluoronaphthatel group.
- the fluoronaphthasel group refers to a group in which at least one hydrogen atom of the naphthatel group is substituted with a fluorine atom, and may be further substituted with another substituent.
- the fluoronaphthal group includes a pendecafluoronaphthacyl group.
- the substituted pentacell group includes a fluoropentacell group.
- the fluorpentacel group refers to a group in which at least one hydrogen atom of a pentacell group is substituted with a fluorine atom, and may be further substituted with another substituent.
- the fluoropentacenyl group includes a tridecafluoropentacenyl group.
- a compound of the formula [13] is obtained by reacting a compound of the formula [11] with a compound of the formula [12] in the presence of a Lewis acid.
- Lewis acid may be used in combination with sodium salt
- the Lewis acid used in Scheme 4 is not particularly limited, and examples thereof include aluminum chloride, zinc chloride, zinc chloride (111), tin chloride (IV), and trifluoride. Boron ether complexes can be used, of which aluminum chloride is preferred.
- the amount of the Lewis acid to be used is 0.1-5.0 equivalents, preferably 0.2-1.0 equivalents, relative to the amount of the raw material.
- the amount of use is 0.1 to 10.0 equivalents, preferably 5.0 to 7.0 equivalents to the raw material.
- the amount of the compound of the formula [2] to be used is 1.0 to 5.0 equivalents, preferably 1.1 to 2.0 equivalents, relative to the compound of the formula [1].
- the reaction temperature is 0-320 ° C, preferably 200-300 ° C.
- the reaction time is preferably 110 hours. After the completion of the reaction, the target compound is obtained by performing ordinary post-treatment and purification.
- the compound represented by the formula [13] is reacted with a fluorinating agent to obtain the compound represented by the formula [14].
- a compound represented by the formula [15] may be formed in addition to the compound represented by the formula [14].
- the compound of the formula [15] can be converted to a compound of the formula [14] by further reacting with a fluorinating agent.
- the compound of formula [16] is obtained by reacting the compound of formula [13] with a fluorinating agent.
- the compound of the formula [2] is obtained by reacting the compound of the formula [14] or [16] with a reducing agent.
- the compound of the formula [22] is obtained by reacting the compound of the formula [21] with a fluorinating agent. In this reaction, a compound of the formula [23] may be formed in addition to the compound of the formula [22]. The compound of the formula [23] is further reacted with a fluorine-containing agent to obtain a compound of the formula [22]. Can be converted to a compound.
- Pentacene-6,13-dione (14) is commercially available, for example, from Aldrich.
- a compound of the formula [32] is obtained by reacting a compound of the formula [31] with a fluorinating agent. In this reaction, the compound of the formula [33] may also be formed. The compound of the formula [33] can be converted to a compound of the formula [32] by further reacting with a fluorinating agent.
- pentacene-5,7,12,14-tetraone (11) can be obtained as a commercial product, for example, from Avocado.
- the oxo group is not fluorinated and has an oxo group. Residual compounds may be formed. These compounds can be further reacted with a fluorinating agent to remove the oxo group and fluorinate.
- a fluorinating agent various kinds of fluorides can be used without particular limitation.
- Group 15 and group 16 fluorides are preferred, and sulfur tetrafluoride is more preferred.
- the preferred amount of sulfur tetrafluoride is 4.0 to 30.0 times the molar amount of the raw material. More preferred amounts of sulfur tetrafluoride used are 12.0 to 30.0 times the molar amount in Scheme 9, 12.0 to 13.0 times the amount of monole in Scheme 12, and Scheme 20 [koo!
- the fluorine-containing agent may be used alone or in combination.
- a mixture of sulfur tetrafluoride and hydrogen fluoride can be used.
- hydrogen fluoride also acts as a solvent.
- the fluorination step only the raw material and the fluoridating agent may be used, or other substances may coexist.
- the coexisting substance can act as a solvent or a catalyst.
- the substance acting as a solvent the above-mentioned hydrogen fluoride, which is not particularly limited as long as the substance becomes a liquid under the reaction conditions, and chlorinated solvents such as dichloromethane and chloroform are exemplified.
- the solvents may be used alone or in combination.
- hydrogen fluoride the amount used is preferably 120 mL per 1 g of raw material.
- the fluorination step may be carried out at normal pressure, but when heating, it is preferred to carry out under pressure.
- the reaction pressure is in the range of 0-20 MPa
- the reaction temperature is in the range of 40 ° C.-320 ° C.
- the reaction time is in the range of 2-150 hours.
- the target compound is obtained by performing ordinary post-treatments and subsequently performing purification.
- purification methods can be used, and include solvent extraction and recrystallization.
- solvent extraction with an organic solvent such as The target compounds (7) and (17) can be obtained by performing the extraction and recrystallization.
- the reducing agent used in the defluorination step is not particularly limited, and a reducing agent generally considered to have a reducing ability is used.
- reducing agents include: simple substance of group 1 element such as lithium, sodium, lithium, rubidium and cesium; simple substance of group 2 element such as beryllium, magnesium, calcium, strontium and norium; scandium, yttrium and lanthanoid Group 3 element such as titanium, zirconium and hafnium; Group 5 element such as vanadium, niobium and tantalum; Group 6 element such as chromium, molybdenum and tungsten; Group 7 element such as manganese and rhenium Simple substance of group 8 element such as iron, ruthenium and osmium; simple substance of group 9 element such as cobalt, rhodium and iridium; simple substance of group 10 element such as nickel, palladium and platinum; copper, silver and gold Group 11 elements such as zinc, cadmium, and mercury Group
- group 13 elements carbon, silicon, germanium, tin, lead, etc. group 14 elements; phosphorus, arsenic, antimony, bismuth Elemental elements of group 15 elements; elemental elements of group 16 elements such as io, selenium and tellurium; sodium oxalate; activated carbon; and cesium cobalt trifluoride; and preferably zinc, iron, copper, nickel and palladium. And more preferably zinc.
- These reducing agents may be used alone or in combination. When zinc is used, it is used in an amount of 6.0 to 200 equivalents, preferably 50 to 100 equivalents, based on the amount of the raw material.
- the reaction is preferably performed in an atmosphere of an inert gas such as nitrogen, helium, neon, or argon, or under vacuum.
- the reaction temperature is from 0 to 600 degrees, preferably from 200 to 300 degrees.
- the reaction time is 1 to 110 hours, preferably 2 to 24 hours.
- the defluorination step may be carried out using only the raw material and the reducing agent, or may be made to coexist with other substances.
- a substance that acts as a solvent or a catalyst can be selected.
- the raw material may be reacted with samarium iodide, zinc, sodium 'benzophenone, and combinations thereof in an organic solvent.
- the organic solvent include ⁇ , ⁇ -dimethylformamide and tetrahydrofuran.
- the target compound is obtained by performing ordinary post-treatments and subsequently performing a purification operation. Conventionally known purification methods can be used, and include solvent extraction and recrystallization.
- GCMS-QP5050A was used.
- a CHN Coda-MT-6 type manufactured by Yanaco Analytical Industries, Ltd. was used.
- 1,2,3,4,8,9,10,11-octafluoro-5,7,12,14-tetrahydroxypentacene-6,13-dione (5 g, 9.68 mmol) was placed in a 500 mL SUS autoclave. After charging, the vessel was cooled to ⁇ 78 ° C., hydrogen fluoride (100 g) was added, followed by sulfur tetrafluoride (25 g, 231 mmol). Thereafter, the reaction vessel was heated to 150 ° C. in a sealed state. At this time, the pressure in the reaction vessel reached 4.0 MPa (gauge pressure).
- reaction vessel After reacting for 96 hours, the reaction vessel was gradually cooled to room temperature, and the low-boiling compounds were slowly discarded in the abatement apparatus. When the internal pressure reached normal pressure, nitrogen was introduced into the vessel to remove any remaining hydrogen fluoride. Thereafter, the reaction product (6.6 g) was extracted with 600 mL of hot-cloth-form, filtered, and the solution was concentrated to obtain 4.8 g of a crude product of compound (7). This was recrystallized in a filter form to obtain 2.5 g (3.87 mmol, yield: 40%) of a pure compound (7).
- reaction vessel After reacting for 68 hours, the reaction vessel was gradually cooled to room temperature, and low-boiling compounds were slowly discarded in the abatement apparatus. When the internal pressure reached normal pressure, nitrogen was introduced into the vessel to remove any remaining hydrogen fluoride. Thereafter, the reaction product (13.3 g) was extracted with 1.5 L of hot-cloth-form, filtered, and recrystallized to obtain 8.0 g of pure compound (7) (12.4 mmol, yield 64%). Obtained.
- reaction vessel After reacting for 66 hours, the reaction vessel was gradually cooled to room temperature, and the low-boiling compounds were slowly dumped into the abatement apparatus. Inside When the internal pressure reached normal pressure, nitrogen was introduced into the vessel to remove any remaining hydrogen fluoride. Thereafter, the reaction product (5.2 g) was extracted with 600 mL of hot-cloth-form, filtered, and the solution was concentrated to obtain 2.0 g of a crude product of compound (7). The filtration residue was recovered, and 3.1 g (5.2 mmol, 61%) of compound (17) was recovered.
- reaction vessel After reacting for 20 hours, the reaction vessel was gradually cooled to room temperature, and the low-boiling compounds were slowly discarded in a scrubber. When the internal pressure reached normal pressure, nitrogen was introduced into the vessel to remove any remaining hydrogen fluoride. Mass spectrometry of the obtained product mixture (1.4 g) revealed that the purity of compound (8) was 90%.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005515201A JP4647496B2 (ja) | 2003-11-04 | 2004-11-02 | フッ素化されたペンタセン誘導体及びそれらの製造方法 |
US10/578,259 US7439407B2 (en) | 2003-11-04 | 2004-11-02 | Fluorinated pentacene derivative and method of producing same |
KR1020067008166A KR101098201B1 (ko) | 2003-11-04 | 2006-04-27 | 불소화된 펜타센 유도체 및 그들의 제조방법 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003373970 | 2003-11-04 | ||
JP2003-373970 | 2003-11-04 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2005042445A1 WO2005042445A1 (ja) | 2005-05-12 |
WO2005042445A2 true WO2005042445A2 (ja) | 2005-05-12 |
WO2005042445A3 WO2005042445A3 (ja) | 2005-07-14 |
Family
ID=34544173
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2004/016248 WO2005042445A2 (ja) | 2003-11-04 | 2004-11-02 | フッ素化されたペンタセン誘導体及びそれらの製造方法 |
Country Status (4)
Country | Link |
---|---|
US (1) | US7439407B2 (ja) |
JP (1) | JP4647496B2 (ja) |
KR (1) | KR101098201B1 (ja) |
WO (1) | WO2005042445A2 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006335719A (ja) * | 2005-06-03 | 2006-12-14 | Asahi Kasei Corp | ポリアセン化合物及びその製造方法並びに有機半導体素子 |
JP2006335720A (ja) * | 2005-06-03 | 2006-12-14 | Asahi Kasei Corp | ポリアセン化合物の製造方法及び有機半導体素子 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005272460A (ja) | 2004-02-25 | 2005-10-06 | Asahi Kasei Corp | ポリアセン化合物及び有機半導体薄膜 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000026339A (ja) * | 1998-07-06 | 2000-01-25 | Tamotsu Takahashi | 縮合多置換多環化合物とその製造方法 |
WO2002019022A1 (en) * | 2000-08-30 | 2002-03-07 | Gentex Corporation | Color-stabilized electrochromic devices |
WO2003016599A1 (fr) * | 2001-08-09 | 2003-02-27 | Asahi Kasei Kabushiki Kaisha | Element a semi-conducteur organique |
WO2003027050A2 (en) * | 2001-09-27 | 2003-04-03 | 3M Innovative Properties Company | Process for preparing pentacene derivatives |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5593812A (en) * | 1995-02-17 | 1997-01-14 | International Business Machines Corporation | Photoresist having increased sensitivity and use thereof |
-
2004
- 2004-11-02 US US10/578,259 patent/US7439407B2/en active Active
- 2004-11-02 WO PCT/JP2004/016248 patent/WO2005042445A2/ja active Application Filing
- 2004-11-02 JP JP2005515201A patent/JP4647496B2/ja active Active
-
2006
- 2006-04-27 KR KR1020067008166A patent/KR101098201B1/ko active IP Right Grant
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000026339A (ja) * | 1998-07-06 | 2000-01-25 | Tamotsu Takahashi | 縮合多置換多環化合物とその製造方法 |
WO2002019022A1 (en) * | 2000-08-30 | 2002-03-07 | Gentex Corporation | Color-stabilized electrochromic devices |
WO2003016599A1 (fr) * | 2001-08-09 | 2003-02-27 | Asahi Kasei Kabushiki Kaisha | Element a semi-conducteur organique |
WO2003027050A2 (en) * | 2001-09-27 | 2003-04-03 | 3M Innovative Properties Company | Process for preparing pentacene derivatives |
Non-Patent Citations (2)
Title |
---|
BURDOU J. ET AL: 'Nucleophilic Replacement in Decafluoroanthracene.' J. CHEM. SOC. CHEM.COMMUN. 1982, pages 534 - 535, XP002987742 * |
MARSCHALK C.: 'Linear pentacene series. I. Synthese of pentacene derivatives and their transformation. II. Demonstration of the presence of the pentacene skeleton,' BULL.SOC.CHIM.5 vol. 4, 1937, pages 1535 - 1546, XP002987741 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006335719A (ja) * | 2005-06-03 | 2006-12-14 | Asahi Kasei Corp | ポリアセン化合物及びその製造方法並びに有機半導体素子 |
JP2006335720A (ja) * | 2005-06-03 | 2006-12-14 | Asahi Kasei Corp | ポリアセン化合物の製造方法及び有機半導体素子 |
Also Published As
Publication number | Publication date |
---|---|
KR101098201B1 (ko) | 2011-12-23 |
US20070083067A1 (en) | 2007-04-12 |
JPWO2005042445A1 (ja) | 2007-08-23 |
JP4647496B2 (ja) | 2011-03-09 |
WO2005042445A3 (ja) | 2005-07-14 |
US7439407B2 (en) | 2008-10-21 |
KR20060117315A (ko) | 2006-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3357608B2 (ja) | アミノスルファートリフルオリドによるフッ素化方法 | |
Duan et al. | Trifluoromethylation of organic halides with methyl halodifluoroacetates—a process via difluorocarbene and trifluoromethide intermediates | |
WO2006001398A1 (ja) | ポリハロゲン化ジアマンタン類及びその誘導体の製造方法 | |
WO2012009818A1 (en) | Protected aldehydes for use as intermediates in chemical syntheses, and processes for their preparation | |
Maury et al. | Unexpected conversion of alkyl azides to alkyl iodides and of aryl azides to N-tert-butyl anilines | |
KR101098201B1 (ko) | 불소화된 펜타센 유도체 및 그들의 제조방법 | |
JP3898515B2 (ja) | 隣位のジフルオロ芳香族化合物およびその中間体の合成 | |
Wade et al. | Polynitro-substituted strained-ring compounds. 2. 1, 2-Dinitrospiropentanes | |
JP4448318B2 (ja) | フッ素化されたナフタセン誘導体及びそれらの製造方法 | |
CN112679328B (zh) | 一种3-三氟甲基-2-环己烯-1-酮的工业化生产方法 | |
JP7341411B2 (ja) | フッ素置換基を有する多環芳香族複素環式化合物の製法 | |
Barlow et al. | Fluorinated acetylenes. Part 13 [1]. Synthesis of 1, 6-diphenyl-3, 3, 4, 4-tetrafluorohexa-1, 5-diyne | |
CN108299445B (zh) | 一种1,5-氮杂螺[2,4]庚烷的合成方法 | |
JP4093842B2 (ja) | ハロゲン化アダマンタン類の製造方法 | |
JP4364545B2 (ja) | 新規なジフルオロテトラヒドロチオフェン1,1−ジオキシド及びその製造方法 | |
JP5315710B2 (ja) | 1−ブロモ−3−フルオロ−5−ジフルオロメチルベンゼンの製造方法 | |
JP2005306857A (ja) | ポリアセン化合物の製造方法 | |
CN117903112A (zh) | 一类含硫的脱氧氟化试剂及其制备方法、应用 | |
CN107417489B (zh) | 一种合成溴代稠环芳烃类化合物的方法 | |
CN116239779A (zh) | 一种用于碘化试剂的二维卤键有机框架材料、其制备方法及应用 | |
JP2531228B2 (ja) | ビフェニル誘導体およびその製造法 | |
JPS61158974A (ja) | (s)−o−ベンジルグリシド−ルの製造法 | |
JP2003221372A (ja) | N,n−ジ置換アミド類の新規製造法 | |
JPS61126077A (ja) | 2−(4−イソブチルフエニル)−1,2−エポキシプロパンの製造法 | |
JPH0739359B2 (ja) | ジクロロ‐(2,2)‐パラシクロファンの製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2005515201 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020067008166 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007083067 Country of ref document: US Ref document number: 10578259 Country of ref document: US |
|
DPEN | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101) | ||
WWP | Wipo information: published in national office |
Ref document number: 1020067008166 Country of ref document: KR |
|
122 | Ep: pct application non-entry in european phase | ||
WWP | Wipo information: published in national office |
Ref document number: 10578259 Country of ref document: US |